1-9 of 9
Amro Aboukameel
Close
Sort by
Journal Articles

The Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit the Growth of MLL-r AML

Md. Hafiz Uddin, Amro Aboukameel, Sharif hasan Siddiqui, Husain Khan, Sahar Bannoura, Abhinav Deol, Jay Yang, Gregory Dyson, Asfar Azmi, Lisa Polin, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2023) 142 (Supplement 1): 4168.
https://doi.org/10.1182/blood-2023-190638
Published: 2023
Journal Articles

Novel Combination of Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit MLL-r AML

Md. Hafiz Uddin, Amro Aboukameel, Husain Khan, Sahar Bannoura, Yiwei Li, Abhinav Deol, Jay Yang, Asfar Sohail Azmi, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 8811–8812.
https://doi.org/10.1182/blood-2022-168151
Published: 2022
Journal Articles

Dual Targeting PAK4 and NAMPT As a Novel Therapeutic Approach for Aggressive Non-Hodgkin's Lymphoma

Suresh Kumar Balasubramanian, Husain Khan, Md. Hafiz Uddin, Amro Aboukameel, Yiwei Li, Jeffrey A. Zonder, William T. Senapedis, Jr., Erkan Baloglu, Ramzi Mohammad, Jatin J. Shah, Yosef Landesman, Sharon Shacham, Michael G. Kauffman, Asfar Sohail Azmi
Journal: Blood
Blood (2021) 138 (Supplement 1): 683.
https://doi.org/10.1182/blood-2021-145615
Published: 2021
Journal Articles

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase 1b Study

Erlene K. Seymour, MD, Yiwei Li, Amro Aboukameel, Radhakrishnan Ramchandren, Golbon Sterbis, Jay Yang, MD, Divaya Bhutani, MD, Ramzi Mohammad, PhD, Asfar Sohail Azmi, PhD, Jeff Zonder, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-140752
Published: 2020
Journal Articles

Bruton Tyrosine Kinase Inhibition in Classical Hodgkin Lymphoma Cell Lines and Animal Models

Irfana Muqbil, PhD, Amro Aboukameel, MS, Ramzi Mohammad, PhD, Asfar Sohail Azmi, PhD, Radhakrishnan Ramchandren, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1536.
https://doi.org/10.1182/blood.V130.Suppl_1.1536.1536
Published: 2017
Journal Articles

Combination of Selinexor and the Proteasome Inhibitor, Bortezomib Shows Synergistic Cytotoxicity in Diffuse Large B-Cells Lymphoma Cells In Vitro and In Vivo

Trinayan Kashyap, MS, Irfana Muqbil, Amro Aboukameel, Boris Klebanov, MA, MS, Ramzi Mohammad, PhD, Asfar Sohail Azmi, PhD, William Senapedis, PhD, Sharon Shacham, PhD MBA, Michael Kauffman, MD PhD, Yosef Landesman, PhD
Journal: Blood
Blood (2016) 128 (22): 4131.
https://doi.org/10.1182/blood.V128.22.4131.4131
Published: 2016
Journal Articles

Development of a Novel Small Molecule CRM-1 Inhibitor for Non Hodgkin's Lymphoma

Asfar Sohail Azmi, Research Associate, Ayad Al-Katib, MD, FACP, Amro Aboukameel, RA, Michael Kauffman, MD, Ph.D., Dilara McCauley, Research Associate, Ramzi Mohammad, PhD, Sharon Shacham, PhD
Journal: Blood
Blood (2011) 118 (21): 598.
https://doi.org/10.1182/blood.V118.21.598.598
Published: 2011
Journal Articles

Superior Anti-Tumor Activity of the CD19-Directed Immunotoxin, SAR3419 to Rituximab in Non-Hodgkin’s Xenograft Animal Models: Preclinical Evaluation.

Amro Aboukameel, MS, Anton-Scott Goustin, PhD, Ramzi Mohammad, PhD, Claudia Zuany-Amorim, PhD, Marie-Christine Bissery, PhD, Ayad M. Al-Katib, MD
Journal: Blood
Blood (2007) 110 (11): 2339.
https://doi.org/10.1182/blood.V110.11.2339.2339
Published: 2007
Journal Articles

Evaluation of TW-37, a pan Bcl-2 Proteins Small-Molecule Inhibitor, Against Spectrum of Human B-Cell Lines and Patient-Derived Samples.

Ramzi M. Mohammad, PhD, Yuan Sun, MSc, Shaomeng Wang, PhD, Amro Aboukameel, MSc, Ayad M. Al-Katib, M.D.
Journal: Blood
Blood (2007) 110 (11): 4521.
https://doi.org/10.1182/blood.V110.11.4521.4521
Published: 2007